Hepcidin and iron metabolism: From laboratory to clinical implications

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1565-1569

  Franchini, Massimo ^a   Montagnana, Martina ^b   Lippi, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Anemia; Hemochromatosis; Hepcidin; Iron

Indexed keywords

FERROPORTIN 1; HEPCIDIN;

GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HEPCIDIN DEFICIENCY; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON KINETICS; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANTIMICROBIAL CATIONIC PEPTIDES; HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS;

EID: 77956470416     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.003     Document Type: Review

References (57)

1. Anderson G.J., Frazer D.M., McLaren G.D. Iron absorption and metabolism. Curr Opin Gastroenterol 2009, 25:129-135.
2. Andrews N.C., Schmidt P.J. Iron homeostasis. Annu Rev Physiol 2007, 69:69-85.
3. Camaschella C, Strati P. Recent advances in iron metabolism and related disorders. Intern Emerg Med 2010 [epub ahead of print].
4. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001, 276:7806-7810.
5. Piperno A., Mariani R., Trombini P., Girelli D. Hepcidin modulation in human diseases: from research to clinic. WJ Gastroenterol 2009, 15:538-551.
6. Forth W., Rummel W. Iron absorption. Physiol Rev 1973, 53:724-792.
7. Su D., Asard H. Three mammalian cytochromes b561 are ascorbate-dependent ferrireductases. FEBS J 2006, 273:3722-3734.
8. Latunde-Dada G.O., Simpson R.J., McKie A.T. Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 2008, 138:991-995.
9. Latunde-Dada G.O., Van der Westhuizen J., Vulpe C.D., Anderson G.J., Simpson R.J., McKie A.T. Molecular and functional roles of duodenal cytochrome B (Dcytb) in iron metabolism. Blood Cells Mol Dis 2002, 29:356-360.
10. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
11. Vulpe C.D., Kuo Y.M., Murphy T.L., et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999, 21:195-199.
12. Zhang A.S., Enns C.A. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program 2009, 207-214.
13. Oates P.S., West A.R. Mechanisms of heme iron absorption: current questions and controversies. World J Gastroenterol 2008, 14:4101-4110.
14. Shayeghi M., Latunde-Dada G.O., Oakhill J.S., et al. Identification of an intestinal heme transporter. Cell 2005, 122:789-801.
15. Quigley J.G., Yang Z., Worthington M.T., et al. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004, 118:757-766.
16. Krause A., Nietz S., Magert H.J., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000, 480:147-150.
17. Ganz T. Nemeth E iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006, 290:G199-G203.
18. Collins J.F., Wessling-Resnick M., Knutson M.D. Hepcidin regulation of iron transport. J Nutr 2008, 138:2284-2288.
19. Pigeon C., Ilyin G., Courselaud B., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001, 276:7811-7819.
20. Frazer D.M., Inglis H.R., Wilkins S.J., et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004, 53:1509-1515.
21. Latunde-Dada G.O., McKie A.T., Simpson R.J. Animal models with enhanced erythropoiesis and iron absorption. Biochim Biophys Acta 2006, 1762:414-423.
22. Nicolas G., Chauvet C., Viatte L., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002, 110:1037-1044.
23. Darshan D., Anderson G.J. Interacting signals in the control of hepcidin expression. Biometals 2009, 22:77-87.
24. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007, 117:1926-1932.
25. McMahon S., Grondin F., McDonald P.P., et al. Hypoxia enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem 2005, 280:6561-6569.
26. Courselaud B., Pigeon C., Inoue Y., et al. C/EBP alpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002, 277:41163-41170.
27. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-2463.
28. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108:3204-3209.
29. Verga Falzacappa M.V., Vujic Spasic M., Kessler R., et al. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007, 109:353-358.
30. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
31. Mena N.P., Esparza A., Tapia V., Valdés P., Núñez M.T. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 2008, 294:G192-G198.
32. Shah Y.M., Matsubara T., Ito S., Yim S.H., Gonzalez F.J. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 2009, 9:152-164.
33. Mastrogiannaki M., Matak P., Keith B., Simon M.C., Vaulont S., Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 2009, 119:1159-1166.
34. Malyszko J. Hepcidin assays: ironing out some details. Clin J Am Soc Nephrol 2009, 4:1015-1016.
35. Castagna A., Campostrini N., Zaninotto F., Girelli D. Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J Proteomics 2010, 73:527-536.
36. Kemna E., Tjalsma H., Laarakkers C., Nemeth E., Willems H., Swinkels D. Novel urine hepcidin assay by mass spectrometry. Blood 2005, 106:3268-3270.
37. Kemna E.H., Tjalsma H., Podust V.N., Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 2007, 53:620-628.
38. Campostrini N., Castagna A., Zaninotto F., et al. Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol 2010, 2010:329646.
39. Li H., Rose M.J., Tran L., et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009, 59:171-180.
40. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M. Immunoassay for human serum hepcidin. Blood 2008, 112:4292-4297.
41. Koliaraki V., Marinou M., Vassilakopoulos T.P., et al. A novel immunological assay for hepcidin quantification in human serum. PLoS ONE 2009, 4:e4581.
42. De Domenico I., Nemeth E., Nelson J.M., et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008, 8:146-156.
43. Kroot J.J., Kemna E.H., Bansal S.S., et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 2009, 94:1748-1752.
44. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med 2006, 57:331-347.
45. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004, 350:2383-2397.
46. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004, 32:131-138.
47. Franchini M. Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol 2006, 81:202-209.
48. De Domenico I., McVey Ward D., Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008, 9:72-81.
49. Kattamis A., Papassotiriou I., Palaiologou D., et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006, 91:809-812.
50. Origa R., Galanello R., Ganz T., et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007, 92:583-588.
51. Nemeth E., Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006, 91:727-732.
52. Miura K., Taura K., Kodama Y., Schnabl B., Brenner D.A. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008, 48:1420-1429.
53. Muckenthaler M.U. Fine tuning of hepcidin expression by positive and negative regulators. Cell Metab 2008, 8:1-3.
54. Melis M.A., Cau M., Congiu R., et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008, 93:1473-1479.
55. Finberg K.E., Heeney M.M., Campagna D.R., et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008, 40:569-571.
56. Agarwal N., Prchal J.T. Anemia of chronic disease (anemia of inflammation). Acta Haematol 2009, 122:103-108.
57. Nemeth E., Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009, 12:78-86.